Effect of drugs on nutritional status and drug-nutrition interactions in older patients.
adverse drug reactions
appetite
drug-nutrition interactions
medications
older patients
Journal
Geriatrics & gerontology international
ISSN: 1447-0594
Titre abrégé: Geriatr Gerontol Int
Pays: Japan
ID NLM: 101135738
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
revised:
23
04
2023
received:
10
03
2023
accepted:
11
05
2023
medline:
6
7
2023
pubmed:
7
6
2023
entrez:
7
6
2023
Statut:
ppublish
Résumé
Older patients are prone to multimorbidity or related polypharmacy, which may cause various adverse drug reactions (ADRs) and a high incidence of drug-related health problems. Although not often noted, ADRs include nutrition-related adverse reactions. Aging, multiple illnesses, mental and psychological problems, declining physical function, and environmental factors can lead to decreased food intake and increased metabolic stress in older people, resulting in energy imbalances that cause malnutrition. ADRs can lead to appetite loss, followed by decreased food intake, which in turn causes malnutrition and deficiencies of various nutrients. However, these nutrition-related ADRs have received less attention. This review article describes drug-nutrition interactions, with a particular focus on older patients. Geriatr Gerontol Int 2023; 23: 465-477.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
465-477Informations de copyright
© 2023 Japan Geriatrics Society.
Références
Kuzuya M. Era of geriatric medical challenges: Multimorbidity among older patients. Geriatr Gerontol Int 2019; 19: 699-704.
Guthrie B, Makubate B, Hernandez-Santiago V, Dreischulte T. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010. BMC Med 2015; 13: 74.
Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr 2017; 17: 230.
Kuzuya M, Hirakawa Y, Suzuki Y et al. Association between unmet needs for medication support and all-cause hospitalization in community-dwelling disabled elderly people. J Am Geriatr Soc 2008; 56: 881-886.
Waring RH, Harris RM, Mitchell SC. Drug metabolism in the elderly: A multifactorial problem? Maturitas 2017; 100: 27-32.
Zazzara MB, Palmer K, Vetrano DL, Carfì A, onder G. Adverse drug reactions in older adults: a narrative review of the literature. Eur Geriatr Med 2021; 12: 463-473.
Cox NJ, Morrison L, Ibrahim K, Robinson SM, Sayer AA, Roberts HC. New horizons in appetite and the anorexia of ageing. Age Ageing 2020; 49: 526-534.
Kuzuya M. Nutritional status related to poor health outcomes in older people: Which is better, obese or lean? Geriatr Gerontol Int 2021; 21: 5-13.
Hirose T, Hasegawa J, Izawa S, Enoki H, Suzuki Y, Kuzuya M. Accumulation of geriatric conditions is associated with poor nutritional status in dependent older people living in the community and in nursing homes. Geriatr Gerontol Int 2014; 14: 198-205.
Izawa S, Enoki H, Hasegawa J, Hirose T, Kuzuya M. Factors associated with deterioration of mini nutritional assessment-short form status of nursing home residents during a 2-year period. J Nutr Health Aging 2014; 18: 372-377.
Umegaki H, Asai A, Kanda S et al. Factors associated with unexpected admissions and mortality among low-functioning older patients receiving home medical care. Geriatr Gerontol Int 2017; 17: 1623-1627.
Chan LN. Drug-nutrient interactions. JPEN J Parenter Enteral Nutr 2013; 37: 450-459.
Boullata JI, Hudson LM. Drug-nutrient interactions: a broad view with implications for practice. J Acad Nutr Diet 2012; 112: 506-517.
Jyrkkä J, Enlund H, Lavikainen P, Sulkava R, Hartikainen S. Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population. Pharmacoepidemiol Drug Saf 2011; 20: 514-522.
Agostini JV, Han L, Tinetti ME. The relationship between number of medications and weight loss or impaired balance in older adults. J Am Geriatr Soc 2004; 52: 1719-1723.
Griep MI, Mets TF, Collys K, Ponjaert-Kristoffersen I, Massart DL. Risk of malnutrition in retirement homes elderly persons measured by the "mini-nutritional assessment". J Gerontol A Biol Sci Med Sci 2000; 55: M57-M63.
Nakamura T, Itoh T, Yabe A et al. Polypharmacy is associated with malnutrition and activities of daily living disability among daycare facility users: A cross-sectional study. Medicine (Baltimore) 2021; 100: e27073.
Loddo S, Salis F, Rundeddu S, Serchisu L, Peralta MM, Mandas A. Nutritional Status and Potentially Inappropriate Medications in Elderly. J Clin Med 2022; 11: 3465.
Kose E, Hirai T, Seki T. Change in number of potentially inappropriate medications impacts on the nutritional status in a convalescent rehabilitation setting. Geriatr Gerontol Int 2019; 19: 44-50.
Gaddey HL, Holder KK. Unintentional weight loss in older adults. Am Fam Physician 2021; 104: 34-40.
Soysal P, Isik AT, Stubbs B et al. Acetylcholinesterase inhibitors are associated with weight loss in older people with dementia: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2016; 87: 1368-1374.
Franx BAA, Arnoldussen IAC, Kiliaan AJ, Gustafson DR. Weight Loss in Patients with Dementia: Considering the Potential Impact of Pharmacotherapy. Drugs Aging 2017; 34: 425-436.
Mora-Navarro MA, Rincón-Sánchez AR, Pacheco-Moisés FP et al. Nutritional Status in Patients with Probable Alzheimer's Disease: Effect of Rivastigmine. J Nutr Health Aging 2021; 25: 340-346.
Tsuno N, Mori T, Ishikawa I et al. Efficacy of rivastigmine transdermal therapy on low food intake in patients with Alzheimer's disease: The attitude towards food consumption in alzheimer's disease patients revive with rivastigmine effects study. Geriatr Gerontol Int 2019; 19: 571-576.
Tecott LH, Sun LM, Akana SF et al. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 1995; 374: 542-546.
Vickers SP, Clifton PG, Dourish CT, Tecott LH. Reduced satiating effect of d-fenfluramine in serotonin 5-HT(2C) receptor mutant mice. Psychopharmacology (Berl) 1999; 143: 309-314.
Gill H, Gill B, El-Halabi S et al. Antidepressant medications and weight change: A narrative review. Obesity (Silver Spring) 2020; 28: 2064-2072.
Pilitsi E, Farr OM, Polyzos SA et al. Pharmacotherapy of obesity: Available medications and drugs under investigation. Metabolism 2019; 92: 170-192.
Weghuber D, Barrett T, Barrientos-Pérez M et al. Once-weekly semaglutide in adolescents with obesity. N Engl J Med 2022; 387: 2245-2257.
Iqbal J, Wu HX, Hu N et al. Effect of glucagon-like peptide-1 receptor agonists on body weight in adults with obesity without diabetes mellitus-a systematic review and meta-analysis of randomized control trials. Obes Rev 2022; 23: e13435.
Gabery S, Salinas CG, Paulsen SJ et al. Semaglutide lowers body weight in rodents via distributed neural pathways. JCI Insight 2020; 5: e133429.
Tulipano G. Integrated or independent actions of metformin in target tissues underlying its current use and new possible applications in the endocrine and metabolic disorder area. Int J Mol Sci 2021; 22: 13068.
Buckley JD, Howe PR. Long-chain omega-3 polyunsaturated fatty acids may be beneficial for reducing obesity-a review. Nutrients 2010; 2: 1212-1230.
Tan ECK, Lexomboon D, Sandborgh-Englund G, Haasum Y, Johnell K. Medications that cause dry mouth as an adverse effect in older people: A systematic review and metaanalysis. J Am Geriatr Soc 2018; 66: 76-84.
Algra Y, Haverkort E, Kok W et al. The association between malnutrition and oral health in older people: A systematic review. Nutrients 2021; 13: 3584.
Wolff A, Joshi RK, Ekström J et al. A guide to medications inducing salivary gland dysfunction, xerostomia, and subjective sialorrhea: A systematic review sponsored by the world workshop on oral medicine VI. Drugs R D 2017; 17: 1-28.
Walshe M. European Society for Swallowing Disorders - European Union Geriatric Medicine Society white paper: oropharyngeal dysphagia as a geriatric syndrome. Clin Interv Aging 2016; 11: 1403-1428.
Miarons M, Campins L, Palomera E, Serra-Prat M, Cabré M, Rofes L. Drugs related to oropharyngeal dysphagia in older people. Dysphagia 2016; 31: 697-705.
Chen S, Cui Y, Ding Y et al. Prevalence and risk factors of dysphagia among nursing home residents in eastern China: a cross-sectional study. BMC Geriatr 2020; 20: 352.
Wolf U, Eckert S, Walter G et al. Prevalence of oropharyngeal dysphagia in geriatric patients and real-life associations with diseases and drugs. Sci Rep 2021; 11: 21955.
Kose E, Hirai T, Seki T, Okudaira M, Yasuno N. Anticholinergic load is associated with swallowing dysfunction in convalescent older patients after a stroke. Nutrients 2022; 14: 2121.
Castejón-Hernández S, Latorre-Vallbona N, Molist-Brunet N, Cubí-Montanyà D, Espaulella-Panicot J. Association between anticholinergic burden and oropharyngeal dysphagia among hospitalized older adults. Aging Clin Exp Res 2021; 33: 1981-1985.
Schiffman SS. Taste and Smell Losses in Normal Aging and Disease. JAMA 1997; 278: 1357-1362.
Tuccori M, Lapi F, Testi A et al. Drug-induced taste and smell alterations: a case/non-case evaluation of an italian database of spontaneous adverse drug reaction reporting. Drug Saf 2011; 34: 849-859.
Schiffman SS. Influence of medications on taste and smell. World J Otorhinolaryngol Head Neck Surg 2018; 4: 84-91.
Rademacher WMH, Aziz Y, Hielema A et al. Oral adverse effects of drugs: Taste disorders. Oral Dis 2020; 26: 213-223.
Hamada N, Endo S, Tomita H. Characteristics of 2278 patients visiting the Nihon University Hospital Taste Clinic over a 10-year period with special reference to age and sex distributions. Acta Otolaryngol Suppl 2002; 546: 7-15.
Ortolani E, Landi F, Martone AM et al. Nutritional status and drug therapy in older adults. J Gerontol Geriatr Res 2013; 2: 123.
Zeino Z, Sisson G, Bjarnason I. Adverse effects of drugs on small intestine and colon. Best Pract Res Clin Gastroenterol 2010; 24: 133-141.
Webb BJ, Subramanian A, Lopansri B et al. Antibiotic exposure and risk for hospital-associated clostridioides difficile infection. Antimicrob Agents Chemother 2020; 64: e02169-e02119.
Usai-Satta P, Bellini M, Morelli O, Geri F, Lai M, Bassotti G. Gastroparesis: New insights into an old disease. World J Gastroenterol 2020; 26: 2333-2348.
Hammer HF. Management of chronic diarrhea in primary care: The gastroenterologists' advice. Dig Dis 2021; 39: 615-621.
Schiller LR, Pardi DS, Spiller R et al. Gastro 2013 APDW/WCOG Shanghai working party report: chronic diarrhea: definition, classification, diagnosis. J Gastroenterol Hepatol 2014; 29: 6-25.
Fávaro-Moreira NC, Krausch-Hofmann S, Matthys C et al. Risk factors for malnutrition in older adults: A systematic review of the literature based on longitudinal data. Adv Nutr. 2016; 7: 507-522.
Camilleri M. Peripheral mechanisms in appetite regulation. Gastroenterology 2015; 148: 1219-1233.
Clemmensen C, Müller TD, Woods SC, Berthoud HR, Seeley RJ, Tschöp MH. Gut-brain cross-talk in metabolic control. Cell 2017; 168: 758-774.
Wysokiński A, Sobów T, Kłoszewska I, Kostka T. Mechanisms of the anorexia of aging-a review. Age (Dordr) 2015; 37: 9821.
Cifuentes L, Camilleri M, Acosta A. Gastric sensory and motor functions and energy intake in health and obesity-therapeutic implications. Nutrients 2021; 13: 1158.
Egboh SC, Abere S. Gastroparesis: A multidisciplinary approach to management. Cureus 2022; 14: e21295.
Mohn ES, Kern HJ, Saltzman E, Mitmesser S, McKay D. Evidence of drug-nutrient interactions with chronic use of commonly prescribed medications: An update. Pharmaceutics 2018; 10: 36.
Prescott JD, Drake VJ, Stevens JF. Medications and micronutrients: Identifying clinically relevant interactions and addressing nutritional needs. J Pharm Technol 2018; 34: 216-230.
Mason P. Important drug-nutrient interactions. Proc Nutr Soc 2010; 69: 551-557.
Vasilakou D, Karagiannis T, Athanasiadou E et al. Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med 2013; 159: 262-274.
Lee PC, Ganguly S, Goh SY. Weight loss associated with sodium-glucose cotransporter-2 inhibition: a review of evidence and underlying mechanisms. Obes Rev 2018; 19: 1630-1641.
Christoffersen BØ, Sanchez-Delgado G, John LM, Ryan DH, Raun K, Ravussin E. Beyond appetite regulation: Targeting energy expenditure, fat oxidation, and lean mass preservation for sustainable weight loss. Obesity (Silver Spring) 2022; 30: 841-857.
de Clercq NC, Groen AK, Romijn JA, Nieuwdorp M. Gut microbiota in obesity and undernutrition. Adv Nutr 2016; 7: 1080-1089.
Asadi A, Shadab Mehr N, Mohamadi MH et al. Obesity and gut-microbiota-brain axis: A narrative review. J Clin Lab Anal 2022; 36: e24420.
Nøhr MK, Pedersen MH, Gille A et al. GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. Endocrinology 2013; 154: 3552-3564.
Bouter KE, van Raalte DH, Groen AK, Nieuwdorp M. Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction. Gastroenterology 2017; 152: 1671-1678.
Weersma RK, Zhernakova A, Fu J. Interaction between drugs and the gut microbiome. Gut 2020; 69: 1510-1519.
Vich Vila A, Collij V, Sanna S et al. Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. Nat Commun 2020; 11: 362.
Collins AL, Aitken TJ, Greenfield VY, Ostlund SB, Wassum KM. Nucleus accumbens acetylcholine receptors modulate dopamine and motivation. Neuropsychopharmacology 2016; 41: 2830-2838.
Mark GP, Shabani S, Dobbs LK, Hansen ST. Cholinergic modulation of mesolimbic dopamine function and reward. Physiol Behav 2011; 104: 76-81.
Falk S, Lund C, Clemmensen C. Muscarinic receptors in energy homeostasis: Physiology and pharmacology. Basic Clin Pharmacol Toxicol 2020; 126: 66-76.
Collamati A, Martone AM, Poscia A et al. Anticholinergic drugs and negative outcomes in the older population: from biological plausibility to clinical evidence. Aging Clin Exp Res 2016; 28: 25-35.
Mehdizadeh D, Hale M, Todd O et al. Associations between anticholinergic medication exposure and adverse health outcomes in older people with frailty: A systematic review and meta-analysis. Drugs Real World Outcomes 2021; 8: 431-458.
Ates Bulut E, Erken N, Kaya D, Dost FS, Isik AT. An increased anticholinergic drug burden index score negatively affect nutritional status in older patients without dementia. Front Nutr 2022; 9: 789986.
Naharci MI, Katipoglu B, Tasci I. Association of anticholinergic burden with undernutrition in older adults: A cross-sectional study. Nutr Clin Pract 2022; 37: 1215-1224.
Kose E, Hirai T, Seki T, Yasuno N. Anticholinergic load and nutritional status in older individuals. J Nutr Health Aging 2020; 24: 20-27.
Lim R, Kalisch Ellett LM, Widagdo IS, Pratt NL, Roughead EE. Analysis of anticholinergic and sedative medicine effects on physical function, cognitive function, appetite and frailty: a cross-sectional study in Australia. BMJ Open 2019; 9: e029221.
Velayudhan L, Lovestone S. Smell identification test as a treatment response marker in patients with Alzheimer disease receiving donepezil. J Clin Psychopharmacol 2009; 29: 387-390.